Table 3 Components of Exoskeleton Utilization. Frequency, dosage and intensity of exoskeleton training in various FDA approved-populations studied where gait outcomes were primary focus
From: A framework for clinical utilization of robotic exoskeletons in rehabilitation
Frequency and Dosage | Intensity | Total Sessions | |
|---|---|---|---|
Sub-Acute Stroke | 4x/week for 4 weeks, 60min walking (n = 17) (7) | * | 16 |
3x/week for 4 weeks, 20min walking (n = 12) (8) | *; adjusted based on speed, support and distance | 12 | |
5x/week for 3 weeks, 60min + 120 conventional (PT/SLP/OT) (n = 38)(9) | Defined as steps/session | 15 | |
Chronic Stroke | 5x/week for 8 weeks 45min + 60min conventional (n = 20) (10) | * | 40 |
3x/week for 6 weeks, 45min (n = 25)(11) | RPE 12–16 | 18 | |
5x/week for 4 weeks for 45min + 60min conventional PT and OT (15) | *; Termination of session if too fatigued | 20 | |
Sub-Acute SCI | 3x/week for 8 weeks, “add on” to existing therapy; up time mean 30–35min (n = 25) (12) | RPE 11–13 | 24 |
Chronic SCI | 3x/week for 8 weeks, “add on” to existing therapy; up time mean 30–35min (n = 27) (12) | RPE 11–13 | 24 |
5x/week for 3 weeks for 60min (n = 4) (13) | * | 15 |